文献速递心脑血管急症

苏格兰院前心脏性胸痛评估研究(ACCESS):前瞻性队列研究

The Ambulance Cardiac Chest Pain Evaluation in Scotland Study (ACCESS): A Prospective Cohort Study.
PubMed 文献 · Ann Emerg Med · 2021-04-27
一句话结论急救人员可用HEAR评分区分院前胸痛风险,但即使联合院前即时cTnI检测,HEART评分也不能安全排除30天主要不良心脏事件。

该前瞻性队列研究由急救人员纳入无诊断性ST段抬高的疑似急性冠脉综合征患者,同期记录HEAR评分,并用院前即时检测设备测cTnI以计算HEART评分;HEAR与HEART评分≤3定义为低危、≥7定义为高危,终点为30天主要不良心脏事件。1,054例患者中284例(27%)发生30天主要不良心脏事件。HEAR≤3识别32%低危患者,敏感度84.9%(95%CI 80.7%~89%);HEAR≥7仅识别3%高危患者,特异度98.7%(95%CI 97.9%~99.5%)。院前即时HEART≤3识别30%低危患者,敏感度87.0%(95%CI 80.7%~93.4%);HEART≥7识别14%高危患者,特异度94.8%(95%CI 92.0%~97.5%)。作者结论认为HEAR评分可用于风险区分,但HEART评分不能安全排除主要不良心脏事件,且仅小部分患者被识别为高危。

要点

  • 1,054例院前疑似急性冠脉综合征、无诊断性ST段抬高患者中,284例(27%)在30天发生主要不良心脏事件。
  • HEAR评分≤3识别32%患者(334/1,054)为低危,敏感度84.9%(95%CI 80.7%~89%)。
  • HEAR评分≥7仅识别3%患者(30/1,054)为高危,特异度98.7%(95%CI 97.9%~99.5%)。
  • 院前即时HEART评分≤3识别30%患者为低危,敏感度87.0%(95%CI 80.7%~93.4%);≥7识别14%为高危,特异度94.8%(95%CI 92.0%~97.5%)。
  • 作者结论:HEAR评分可用于风险区分,但HEART评分即使联合院前即时cTnI检测也不能安全排除主要不良心脏事件,仅小部分患者被识别为高危。

适用人群与场景

  • 急救人员前瞻性纳入的疑似急性冠脉综合征且心电图无诊断性ST段抬高的患者,院前场景;共1,054例,年龄64岁(SD 15岁),42%为女性。

诊断标准与关键阈值

  • HEAR评分≤3定义为低危,≥7定义为高危;HEART评分≤3定义为低危,≥7定义为高危;终点为30天主要不良心脏事件。

研究设计与关键结果

  • 前瞻性队列研究,纳入1,054例院前疑似急性冠脉综合征、无诊断性ST段抬高的患者;284例(27%)发生30天主要不良心脏事件。
  • HEAR评分在所有患者中计算,院前即时cTnI检测在357例(34%)中可用。
  • HEAR≤3识别32%患者(334/1,054)为低危,敏感度84.9%(95%CI 80.7%~89%);HEAR≥7识别3%患者(30/1,054)为高危,特异度98.7%(95%CI 97.9%~99.5%)。
  • 院前即时HEART≤3识别30%患者为低危,敏感度87.0%(95%CI 80.7%~93.4%);HEART≥7识别14%患者为高危,特异度94.8%(95%CI 92.0%~97.5%)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为急救人员可用HEAR评分区分院前胸痛患者风险,但HEART评分即使联合院前即时cTnI检测也不能安全排除30天主要不良心脏事件,且仅小部分患者被识别为高危。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To determine whether risk stratification in the out-of-hospital setting could identify patients with chest pain who are at low and high risk to avoid admission or aid direct transfer to cardiac centers.

METHODS: Paramedics prospectively enrolled patients with suspected acute coronary syndrome without diagnostic ST-segment elevation on the ECG. The History, ECG, Age and Risk Factors (HEAR) score was recorded contemporaneously, and out-of-hospital samples were obtained to measure cardiac Troponin I (cTnI) level on a point-of-care device, to allow calculation of the History, ECG, Age, Risk Factors, and Troponin (HEART) score. HEAR and HEART scores less than or equal to 3 and greater than or equal to 7 were defined as low and high risk for major adverse cardiac events at 30 days.

RESULTS: Of 1,054 patients (64 years [SD 15 years]; 42% women), 284 (27%) experienced a major adverse cardiac event at 30 days. The HEAR score was calculated in all patients, with point-of-care cTnI testing available in 357 (34%). A HEAR score less than or equal to 3 identified 32% of patients (334/1,054) as low risk, with a sensitivity of 84.9% (95% confidence interval [CI] 80.7% to 89%), whereas a score greater than or equal to 7 identified just 3% of patients (30/1,054) as high risk, with a specificity of 98.7% (95% CI 97.9% to 99.5%). A point-of-care HEART score less than or equal to 3 identified a similar proportion as low risk (30%), with a sensitivity of 87.0% (95% CI 80.7% to 93.4%), whereas a score greater than or equal to 7 identified 14% as high risk, with a specificity of 94.8% (95% CI 92.0% to 97.5%).

CONCLUSION: Paramedics can use the HEAR score to discriminate risk, but even when used in combination with out-of-hospital point-of-care cTnI testing, the HEART score does not safely rule out major adverse cardiac events, and only a small proportion of patients are identified as high risk.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Cooper JG, Ferguson J, Donaldson LA, et al. The Ambulance Cardiac Chest Pain Evaluation in Scotland Study (ACCESS): A Prospective Cohort Study. Ann Emerg Med. 2021. PMID: 33926756. doi:10.1016/j.annemergmed.2021.01.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。